Clinical Trial Update: Open Label Study of NVP+CBV Treatment in Women Who Have Received sdNVP for the pMTCT of HIV [Phase 4]

View source ↗

Summary

Open-label Phase 4 study evaluating nevirapine plus Combivir in women previously exposed to sdNVP for prevention of mother-to-child transmission of HIV; the tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome

Drugs mentioned

• COMBIVIR (Lamivudine and Zidovudine)
• Nevirapine (Viramune) (Nevirapine)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Acquired Immunodeficiency Syndrome | Phase 4 | Status: COMPLETED